Abstract:Emerging evidence suggests that GSK3β, a redox-sensitive transducer downstream of insulin signaling, acts as a convergent point for myriad pathways implicated in kidney injury, repair, and regeneration. However, its role in diabetic kidney disease remains controversial. In cultured glomerular podocytes, exposure to a milieu of type 2 diabetes elicited prominent signs of podocyte injury and degeneration, marked by loss of homeostatic marker proteins like synaptopodin, actin cytoskeleton disruption, oxidative stress and apoptosis, and stress-induced premature senescence, as shown by increased staining for senescence-associated β-galactosidase activity, amplified formation of γH2AX foci, and elevated expression of mediators of senescence signaling, like p21 and p16INK4A. These degenerative changes coincided with GSK3β hyperactivity, as evidenced by GSK3β overexpression and reduced inhibitory phosphorylation of GSK3β, and were averted by tideglusib, a highly-selective small molecule inhibitor of GSK3β. In agreement, post-hoc analysis of a publicly-available glomerular transcriptomics dataset from patients with type 2 diabetic nephropathy revealed that the curated diabetic nephropathy-related gene set was enriched in high GSK3β expression group. Mechanistically, GSK3β-modulated nuclear factor Nrf2 signaling is involved in diabetic podocytopathy, because GSK3β knockdown reinforced Nrf2 antioxidant response and suppressed oxidative stress, resulting in an improvement in podocyte injury and senescence. Conversely, ectopic expression of the constitutively active mutant of GSK3β impaired Nrf2 antioxidant response and augmented oxidative stress, culminating in an exacerbated diabetic podocyte injury and senescence. Moreover, IRS-1 was found to be a cognate substrate of GSK3β for phosphorylation at IRS-1S332, which negatively regulates IRS-1 activity. GSK3β hyperactivity promoted IRS-1 phosphorylation, denoting a desensitized insulin signaling. Consistently, in vivo in db/db mice with diabetic nephropathy, GSK3β was hyperactive in glomerular podocytes, associated with IRS-1 hyperphosphorylation, impaired Nrf2 response and premature senescence. Our finding suggests that GSK3β is likely a novel therapeutic target for treating type 2 diabetic glomerular injury.

Glycogen Synthase Kinase 3β Dictates Podocyte Motility and Focal Adhesion Turnover by Modulating Paxillin Activity: Implications for the Protective Effect of Low-Dose Lithium in Podocytopathy

Fine-tuning of NFκB by Glycogen Synthase Kinase 3β Directs the Fate of Glomerular Podocytes Upon Injury.

Glycogen Synthase Kinase 3β Orchestrates Microtubule Remodeling in Compensatory Glomerular Adaptation to Podocyte Depletion.

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

Pharmacological Targeting of GSK3β Confers Protection Against Podocytopathy and Proteinuria by Desensitizing Mitochondrial Permeability Transition

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Age-related GSK3 Overexpression Drives Podocyte Senescence and Glomerular Aging

Delayed Administration of a Single Dose of Lithium Promotes Recovery from AKI.

Fine-Tuning Of Nf Kappa B By Glycogen Synthase Kinase 3 Beta Directs The Fate Of Glomerular Podocytes Upon Injury

The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.

The Redox-Sensitive GSK3β is a Key Regulator of Glomerular Podocyte Injury in Type 2 Diabetic Kidney Disease

Valproate Hampers Podocyte Acquisition of Immune Phenotypes Via Intercepting the GSK3β Facilitated NFkB Activation

Liver X Receptor Activation Induces Podocyte Injury Via Inhibiting Autophagic Activity

Podocyte Autophagic Activity Plays a Protective Role in Renal Injury and Delays the Progression of Podocytopathies.

Camp Signaling Prevents Podocyte Apoptosis Via Activation of Protein Kinase A and Mitochondrial Fusion

Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice

Lithium Targeting of AMPK Protects Against Cisplatin-Induced Acute Kidney Injury by Enhancing Autophagy in Renal Proximal Tubular Epithelial Cells.

C5a-C5aR1 Axis Controls Mitochondrial Fission to Promote Podocyte Injury in Lupus Nephritis

Pulmonary , gastrointestinal and urogenital pharmacology Lithium exacerbates hepatic ischemia / reperfusion injury by inhibiting GSK-3 b / NFk B-mediated protective signaling in mice

Dysfunction of the PGC-1α-mitochondria Axis Confers Adriamycin-Induced Podocyte Injury.

Serum and Glucocorticoid-Inducible Kinase 3/Nedd4-2 Signaling Pathway Participates in Podocyte Injury by Regulating the Stability of Nephrin